Pharma Journalist -

SMi Reports: Team Consulting to lead the Injectable Drug Delivery workshop on 12th May 2020 The 3rd annual Injectable Drug Delivery, will commence on the 13th – 14th May 2020 in…
Read More...

The agenda for Smithers' 9th Extractables and Leachables USA Conference, taking place in Bethesda, MD, April 20-22, 2020, is officially released! Smithers, a leading authority for…
Read More...

Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) for selpercatinib (LOXO-292), for the…
Read More...

Galapagos NV announces that the US Food & Drug Administration (FDA) and the European Commission (EC) have granted investigational autotaxin inhibitor GLPG1690 ‘orphan drug…
Read More...

vasopharm GmbH, a privately held biopharmaceutical company focusing on novel therapeutics for the treatment of cerebrovascular diseases, is pleased to announce that enrolment into the…
Read More...

AgeX Therapeutics, Inc., a biotechnology company developing therapeutics for human aging and regeneration, announced a research collaboration with a Japanese biopharma company utilizing…
Read More...

Lonza announced that a clinical manufacturing agreement is in place with Rocket Pharmaceuticals, Inc., a clinical-stage company advancing an integrated and sustainable pipeline of…
Read More...

SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, announces it has…
Read More...

Incyte announced positive topline results from its randomized, vehicle-controlled, pivotal Phase 3 TRuE-AD2 study evaluating the safety and efficacy of ruxolitinib cream in adolescent…
Read More...

Kite, a Gilead Company announced that the company’s Marketing Authorization Application (MAA) for KTE-X19, an investigational chimeric antigen receptor (CAR) T cell therapy for the…
Read More...